Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 6/20 | 0.46 |
| ▸ | NOS1 | P29475 | 5/20 | 0.46 |
| ▸ | NOS3 | P29474 | 2/20 | 0.46 |
| ▸ | ARG1 | P05089 | 1/20 | 0.44 |
| ▸ | ARG2 | P78540 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 5/20 | 0.42 |
| ▸ | BHMT | Q93088 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | GGT1 | P19440 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14956142 | 1.00 | NOS2 (0.46) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL4954761 | 1.00 | NOS2 (0.46) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL6517552 | 1.00 | NOS2 (0.46) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL8746612 | 0.98 | NOS2 (0.45) | NOS2NOS1NOS3ARG1ARG2 | |
| Hydrogen Sulfide SCHEMBL8495952 | 0.98 | NOS2 (0.45) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL1667369 | 0.84 | KIF11 (0.41) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL6835164 | 0.84 | KIF11 (0.41) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL3703131 | 0.84 | KIF11 (0.41) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL15932236 | 0.82 | ARG1 (0.48) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL2591190 | 0.82 | ARG1 (0.48) | NOS2NOS1NOS3ARG1ARG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2138 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12012593-B2 | Modified peptide display | Miti Biosystems GmbH (AT) | 2024-06-18 | — | — | US | claimed |
| WO-2023150887-A1 | LANTHIPEPTIDES AND METHODS OF USE | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2023-08-17 | — | — | WO | claimed |
| US-20220325274-A1 | MODIFIED PEPTIDE DISPLAY | Miti Biosystems GmbH (AT) | 2022-10-13 | — | — | US | claimed |
| EP-3268383-B1 | CYCLIC GALANIN-ANALOGS AND USES THEREOF | LANTHIOPEP BV (NL) | 2021-12-01 | — | — | EP | claimed |
| CN-106170492-B | Cyclic Apelin analogs | 兰硫代佩普有限公司 | 2020-08-21 | — | — | CN | claimed |
| CN-110536695-A | Cell-targeting molecule including deimmunized shiga toxin A Effect of subunit and CD8+ t cell epitope | MOLECULAR TEMPLATES INC | 2019-12-03 | — | — | CN | claimed |
| CN-107231803-B | Pharmaceutical formulations of tropomyosin-related kinase (TRK) inhibitors | 建新公司 | 2019-12-03 | — | — | CN | claimed |
| CN-110508828-A | The preparation method of fluorescent red-orange copper nanocluster based on l-methionine | UNIV HUAIBEI NORMAL | 2019-11-29 | — | — | CN | claimed |
| CN-110495604-A | Plant element composition and its producing method | SHANDONG MUHUA BIOLOGICAL TECH CO LTD | 2019-11-26 | — | — | CN | claimed |
| CN-110484466-A | A method of improving thermophilic anaerobic bacillus fermenting property | UNIV SOUTH CHINA TECH | 2019-11-22 | — | — | CN | claimed |
| US-20060183673-A1 | Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof | VICURON PHARMACEUTICALS INC. (US) | 2006-08-17 | — | — | US | claimed |
| WO-2006080920-A1 | ANTIBIOTIC 107891, ITS FACTORS A1 AND A2, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS, AND USE THEREOF | VICURON PHARMACEUTICALS INC. (US) | 2006-08-03 | — | — | WO | claimed |
| WO-2006075988-A1 | ANTIBIOTIC 107891, ITS FACTORS A1 AND A2, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS, AND USE THEREOF | VICURON PHARMACEUTICALS INC. (US) | 2006-07-20 | — | — | WO | claimed |
| CN-1794986-A | Novel methods for the treatment of cancer | LANKENAU INST MEDICAL RES (US) | 2006-06-28 | — | — | CN | claimed |
| EP-1646646-A1 | ANTIBIOTIC 107891, ITS FACTORS A1 AND A2, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS, AND USE THEREOF. | Vicuron Pharmaceuticals, Inc. (US) | 2006-04-19 | — | — | EP | claimed |
| CN-1667119-A | Adult stem cell and its culturing method and use | UNIV PLA 2ND MILITARY MEDICAL (CN) | 2005-09-14 | — | — | CN | claimed |
| WO-2005019250-A1 | STAPHYLOCOCCUS ANTIBIOTIC PEPTIDES WITH A BROAD SPECTRUM OF ACTION | ACE BIOSCIENCES A/S (DK) | 2005-03-03 | — | — | WO | claimed |
| WO-2005014628-A1 | ANTIBIOTIC 107891, ITS FACTORS A1 AND A2, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS, AND USE THEREOF. | VICURON PHARMACEUTICALS INC. (US) | 2005-02-17 | — | — | WO | claimed |
| CN-1560236-A | Reagent of cell culture and application thereof | 中国人民解放军第二军医大学 | 2005-01-05 | — | — | CN | claimed |
| EP-1481986-A1 | Antibiotic 97518, pharmaceutically acceptable salts and compositions, and use thereof | Vicuron Pharmaceuticals, Inc. (US) | 2004-12-01 | — | — | EP | claimed |